As of 2026-04-15, the EV/EBITDA ratio of Surgery Partners Inc (SGRY) is -31.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SGRY's latest enterprise value is 5,157.70 mil USD. SGRY's TTM EBITDA according to its financial statements is -166.00 mil USD. Dividing these 2 quantities gives us the above SGRY EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.2x - 12.7x | 9.9x |
| Forward P/E multiples | 9.1x - 11.0x | 10.3x |
| Fair Price | (34.76) - 13.23 | (14.35) |
| Upside | -365.3% - 1.0% | -209.5% |
| Date | EV/EBITDA |
| 2026-04-14 | -31.07 |
| 2026-04-13 | -31.06 |
| 2026-04-10 | -30.92 |
| 2026-04-09 | -30.95 |
| 2026-04-08 | -30.72 |
| 2026-04-07 | -30.71 |
| 2026-04-06 | -30.45 |
| 2026-04-02 | -30.35 |
| 2026-04-01 | -30.42 |
| 2026-03-31 | -30.15 |
| 2026-03-30 | -29.90 |
| 2026-03-27 | -29.82 |
| 2026-03-26 | -30.10 |
| 2026-03-25 | -30.25 |
| 2026-03-24 | -30.21 |
| 2026-03-23 | -30.20 |
| 2026-03-20 | -30.06 |
| 2026-03-19 | -30.25 |
| 2026-03-18 | -30.49 |
| 2026-03-17 | -30.72 |
| 2026-03-16 | -30.52 |
| 2026-03-13 | -30.51 |
| 2026-03-12 | -30.79 |
| 2026-03-11 | -31.37 |
| 2026-03-10 | -30.95 |
| 2026-03-09 | -31.23 |
| 2026-03-06 | -31.27 |
| 2026-03-05 | -31.86 |
| 2026-03-04 | -31.83 |
| 2026-03-03 | -31.71 |
| 2026-03-02 | -33.24 |
| 2026-02-27 | -32.94 |
| 2026-02-26 | -32.84 |
| 2026-02-25 | -32.93 |
| 2026-02-24 | -32.85 |
| 2026-02-23 | -32.93 |
| 2026-02-20 | -32.97 |
| 2026-02-19 | -32.82 |
| 2026-02-18 | -33.32 |
| 2026-02-17 | -33.02 |
| 2026-02-13 | -32.91 |
| 2026-02-12 | -32.93 |
| 2026-02-11 | -32.55 |
| 2026-02-10 | -31.72 |
| 2026-02-09 | -31.37 |
| 2026-02-06 | -31.43 |
| 2026-02-05 | -31.33 |
| 2026-02-04 | -31.81 |
| 2026-02-03 | -31.94 |
| 2026-02-02 | -32.40 |